Redcare Pharmacy(OTC) SAEYY

Market Cap$1.52B

Since IPO (2020)-57%

5 Year-59%

1 Year-20%

1 Month+38%

$8.28

+0.00%

+0.00Today

Redcare Pharmacy last closing stock price
Metric	Price	Date
Last close	USD 8.28	2026-06-22

Redcare Pharmacy stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+50.55%	USD 5.50	2026-06-09
1 month	+38.12%	USD 6.00	2026-05-19
3 month	+107%	USD 4.00	2026-03-24
Year to date	+10.4%	USD 7.50	2025-12-23
1 year	-20.38%	USD 10.40	2025-06-20
3 year	-18.58%	USD 10.17	2023-06-23
5 year	-58.81%	USD 20.10	2021-06-18
Since inception	-56.85%	USD 17.50	2020-10-28

Redcare Pharmacy Financials at a Glance

Market Cap

$1.52B

Revenue (TTM)

€3.22B

Net Income (TTM)

-€41.94M

EPS (TTM)

-$0.24

P/E Ratio

-30.96

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$8.28

Volume

260

Open

$8.28

Price

$8.28

Volume

260

Open

$8.28

Previous Close

$8.28

Daily Range

$7.55 - $7.55

52-Week Range

$3.59 - $12.15

Estimated Earnings Date

Oct 29, 2025

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$8.28

Volume

260

Open

$8.28

Previous Close

$8.28

Daily Range

$7.55 - $7.55

52-Week Range

$3.59 - $12.15

Estimated Earnings Date

Oct 29, 2025

SAEYY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Redcare Pharmacy

Redcare Pharmacy N.V. operates as an internet-based pharmacy, serving customers across seven European nations. The company offers a wide range of products, including prescribed and over-the-counter medications, health and beauty items, and nutritional supplements.

Products and Services

Prescription and over-the-counter medications
Health and beauty products
Nutritional supplements

Growth Outlook

Revenue of €853.5 million in Q2 2026, showing strong market demand
Gross profit margin improved to 22.1% in Q2 2026
Expansion into new European markets expected to drive future growth

Financial Highlights

Net income of €4.7 million in Q2 2026, a positive turnaround
Operating income of €12.3 million in Q2 2026, indicating operational efficiency
Current ratio of 1.59, reflecting strong liquidity position

Redcare Pharmacy N.V. has established itself as a key player in the online pharmacy sector, leveraging technology to enhance customer experience and streamline operations. The company's recent financial performance indicates a positive trajectory, with significant revenue growth and improved profitability metrics. The expansion into new markets presents additional opportunities for growth, positioning Redcare Pharmacy favorably within the competitive landscape of the healthcare distribution industry. Investors may find the company's strategic initiatives and financial resilience appealing as it continues to navigate the evolving market dynamics.

AI Generated • Aug 1, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

2,649

CEO

Olaf Heinrich

Website

www.redcare-pharmacy.com

Headquarters

Sevenum, LI 5975 WD, NL

SAEYY Financials

Key Financial Metrics (TTM)

Gross Margin

20.27%

Operating Margin

-0.32%

Net Income Margin

-1.31%

Return on Equity

-9.00%

Return on Capital

-2.61%

Return on Assets

-3.64%

Earnings Yield

-3.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.52B

Shares Outstanding

201.79M

Volume

260

Avg. Volume

58.952

Financials (TTM)

Gross Profit

€653.34M

Operating Income

-€10.12M

EBITDA

€67.04M

Operating Cash Flow

-€10.06M

Capital Expenditure

-€85.71M

Free Cash Flow

-€95.77M

Cash & ST Invst.

€118.90M

Total Debt

€1.30M

Redcare Pharmacy Performance Analysis

Redcare Pharmacy annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 1,265,743,020	1.0%
2023	2023-12-31	EUR 1,944,665,340	53.6%
2024	2024-12-31	EUR 2,564,229,065	31.9%
2025	2025-12-31	EUR 3,319,034,895	29.4%

Redcare Pharmacy sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	1.4%
Q4	2025-12-31	9.5%
Q1	2026-03-31	9.6%
Q2	2026-06-30	-1.2%

Redcare Pharmacy annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -0.45	-7.5%
2023	2023-12-31	EUR -0.07	-85.1%
2024	2024-12-31	EUR -0.25	262.2%
2025	2025-12-31	EUR -0.21	-13.7%

Redcare Pharmacy sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-176.6%
Q4	2025-12-31	-302.8%
Q1	2026-03-31	63.4%
Q2	2026-06-30	100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€853.50M

+20.3%

Gross Profit

€188.60M

+11.8%

Gross Margin

22.10%

N/A

Market Cap

$1.52B

N/A

Market Cap/Employee

$833.91K

N/A

Employees

1,827

N/A

Net Income

€4.70M

-49.8%

EBITDA

€29.30M

-8.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€118.90M

-62.3%

Total Debt

€1.30M

+22.2%

Accounts Receivable

€152.80M

+28.2%

Inventory

€213.30M

+31.8%

Long Term Debt

€0.00

-100.0%

Short Term Debt

€1.30M

+22.2%

Return on Assets

-3.64%

N/A

Return on Invested Capital

-1.26%

N/A

Free Cash Flow

-€11.60M

-212.4%

Operating Cash Flow

€10.80M

-67.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PHMMFPharma Mar, S.A.

PHMMFPharma Mar, S.A.$86.09+0.00%

DRWKFDrägerwerk AG & Co. KGaA

DRWKFDrägerwerk AG & Co. KGaA$100.47+0.00%

RTEZRest Ez Inc.

RTEZRest Ez Inc.$70.00+0.00%

ZRSEFDocMorris AG

ZRSEFDocMorris AG$10.24+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$200.75+0.03%

AAPLApple

AAPLApple$308.91-0.07%

AMZNAmazon

AMZNAmazon$271.58+0.15%

INTCIntel

INTCIntel$90.20-0.01%

FCUVFocus Universal

FCUVFocus Universal$11.60+5.17%

NOKNokia

NOKNokia$9.14+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.62+0.02%

Questions About SAEYY

What is the current price of Redcare Pharmacy?

Redcare Pharmacy is trading at $8.28 per share.

What is the 52-week range for Redcare Pharmacy?

Over the past 52 weeks, Redcare Pharmacy has traded between $3.59 and $12.15.

How much debt does Redcare Pharmacy have?

As of the most recent reporting period, Redcare Pharmacy reported total debt of €405.53M.

How much cash does Redcare Pharmacy have on hand?

Redcare Pharmacy reported €87.23M in cash and cash equivalents in its most recent financial results.

What is Redcare Pharmacy’s dividend yield?

Redcare Pharmacy does not currently have a dividend yield.

Redcare Pharmacy(OTC) SAEYY

Redcare Pharmacy Financials at a Glance

SAEYY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Redcare Pharmacy

SAEYY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Redcare Pharmacy Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SAEYY

What is the current price of Redcare Pharmacy?

What is the 52-week range for Redcare Pharmacy?

How much debt does Redcare Pharmacy have?

How much cash does Redcare Pharmacy have on hand?

What is Redcare Pharmacy’s dividend yield?

Premium Investing Services